Related Experiment Video
Updated: Sep 14, 2025
04:14
Laparoscopic Choledochal Cyst Excision and Roux-en-Y Choledochojejunostomy in Adults
Published on: February 28, 2025
215
Choledochal Cysts in Children: A Single-Center Study in South India
Venkat Kumar Raju Cherukuri1, Shilpa Radhakrishnan2, R Bhanu Vikraman Pillai3
1Pediatrics, Amrita Institute of Medical Sciences and Research Center, Kochi, IND.
Cureus
|July 22, 2025
Summary
This study analyzed pediatric choledochal cysts in South India, finding Type I cysts most common and abdominal pain the primary symptom. Early diagnosis and surgical intervention are crucial for improving outcomes in children with these rare biliary tract anomalies.
Area of Science:
- Pediatric Gastroenterology
- Hepatobiliary Surgery
- Congenital Anomalies
Background:
- Choledochal cysts are rare congenital biliary tract anomalies with limited pediatric data, especially in South India.
- Understanding their clinical spectrum, management, and outcomes is vital for improving pediatric care.
Purpose of the Study:
- To analyze the clinical presentation, types, comorbidities, management, and long-term outcomes of pediatric choledochal cysts.
- To provide insights into the disease profile in South India over a 20-year period.
Main Methods:
- Retrospective audit of hospital records from 147 pediatric patients.
- Data collected included clinical presentation, radiological findings, laboratory investigations, management, and outcomes.
Main Results:
- Female predominance (M:F ratio 1:2.4) with a mean age of 3.4 months at presentation.
- Type I cysts were most frequent (63%), followed by Type IV (31%). Abdominal pain was the most common symptom (58%).
- Pancreatitis occurred in 20% of patients, and 12% had renal anomalies. Surgical intervention was performed in 75%.
Conclusions:
- Pediatric choledochal cysts in South India present with specific characteristics, including a high prevalence of Type I cysts and frequent abdominal pain.
- Early diagnosis and surgical intervention are recommended to mitigate long-term complications like chronic liver disease and portal hypertension.
- Further multicenter studies are necessary to enhance understanding of disease progression and optimize patient outcomes.
